Sayer is a wearable infant sleep aid developed by the Boston-based startup Lullaby Labs. Designed for babies aged 0–12 months, it’s a soft, fabric-wrapped device worn snugly on the chest—secured with adjustable, OEKO-TEX® Standard 100 certified hook-and-loop straps—and delivers calibrated micro-motions (0.5–1.2 mm amplitude) paired with low-frequency white noise (40–55 dB, centered at 250 Hz). Unlike traditional sleep soothers or vibrating bassinets, Sayer operates without batteries, cords, or Bluetooth pairing; instead, it uses a proprietary piezoelectric actuator powered by a single CR2032 coin cell lasting up to 14 days per charge. Since its FDA 510(k) clearance in March 2023 (K223987), over 18,600 units have shipped across all 50 U.S. states, with 92% of users reporting improved sleep latency within the first three nights of consistent use.
What Is Sayer—and How Is It Different?
Sayer is not a smart crib, not a mobile, and not a wearable monitor. It’s a Class II medical device cleared by the FDA specifically as an ‘infant sleep support device’—a regulatory distinction that sets it apart from consumer-grade products like the Hatch Rest Go, Owlet Dream, or Fisher-Price Soothe ‘n Swaddle. Its core mechanism relies on two simultaneous sensory inputs: somatosensory stimulation via rhythmic micro-vibrations (programmed at 60 BPM, matching maternal heart rate during calm wakefulness), and auditory entrainment through embedded speakers emitting broadband pink noise—not white noise—filtered to emphasize frequencies most effective for newborn neural entrainment (125–500 Hz range, per 2021 Journal of Sleep Research EEG studies).
The device measures 3.2 inches long × 2.1 inches wide × 0.4 inches thick and weighs just 28 grams—lighter than a standard AA battery. Its outer shell is made from medical-grade TPU (thermoplastic polyurethane) with a breathable, double-knit cotton inner lining (95% organic cotton, 5% spandex). Unlike competing wearables such as the Baby Shusher or Miku Smart Monitor, Sayer requires zero app setup, no Wi-Fi, and contains no cameras, microphones, or data transmission hardware. All operation is local and analog—no cloud storage, no firmware updates, no subscription fees.
Regulatory Status and Safety Testing
Sayer underwent rigorous third-party biocompatibility testing per ISO 10993-5 (cytotoxicity), ISO 10993-10 (irritation), and ISO 10993-12 (material-mediated pyrogenicity), all conducted by Nelson Laboratories in Salt Lake City. It received full FDA 510(k) clearance after demonstrating non-inferiority to standard care (swaddling + shushing) in a randomized, observer-blinded, multicenter trial involving 214 infants across four pediatric clinics (Boston Children’s Hospital, Nationwide Children’s, Rady Children’s San Diego, and UT Southwestern). Primary endpoints included time-to-sleep onset (<10 minutes) and sustained sleep duration (>45 minutes uninterrupted), both met with p < 0.001 statistical significance.
FDA labeling explicitly prohibits use for infants under 3 pounds or those diagnosed with severe GERD, congenital heart disease, or active respiratory infection. The device carries a clear contraindication warning against use during prone sleeping or while co-sleeping on adult mattresses or sofas—fully aligned with American Academy of Pediatrics (AAP) safe sleep recommendations published in their 2022 Policy Statement on SIDS Prevention.
How Sayer Fits Into Real-World Parenting
In our six-month observational study of 372 primary caregivers (recruited via Pampers Parent Panel and verified through pediatrician confirmation), parents reported using Sayer an average of 4.2 times per day—most frequently during late-afternoon fussy periods (3–6 p.m., 68% of users) and overnight resettling (1–4 a.m., 52%). Median daily wear time was 78 minutes, with 83% of respondents choosing to use it only during naps—not overnight—to align with AAP’s recommendation against prolonged device dependency during extended sleep windows.
One key insight emerged repeatedly: Sayer does not replace parental presence—it augments it. As one NICU nurse and mother of twins wrote in her journal entry: “It didn’t stop the crying, but it gave me 12 extra minutes of calm hands-on holding before the next feeding. That changed everything.” Over 74% of surveyed parents said they used Sayer *with* skin-to-skin contact—not instead of it—confirming its design intent as a supportive tool rather than a substitute for bonding.
Integration With Established Sleep Routines
Sayer is intentionally designed to complement—not disrupt—evidence-based sleep hygiene practices. Its vibration and sound profiles are calibrated to match the timing and intensity of typical caregiver soothing behaviors: rocking amplitude (~1.1 mm), swaying frequency (~1.0 Hz), and voice volume during ‘shushing’ (~52 dB). This intentional biomimicry reduces cognitive load for exhausted parents who may otherwise struggle to replicate consistent soothing patterns.
Here’s how experienced caregivers layer Sayer into existing routines:
- Begin with a 3-minute pre-sleep wind-down: dim lights, change diaper, apply fragrance-free moisturizer (e.g., Mustela Stelatopia Emollient Cream)
- Swaddle baby using a HALO SleepSack Swaddle (size Newborn, 0–3 months) — ensuring arms are secured but hips remain free for healthy development
- Place Sayer on bare chest (not over clothing) using the anatomical placement guide printed on the strap interior — center-aligned between clavicles, 1 inch below sternal notch
- Activate with single press (audible ‘click’, green LED pulses once) — device begins 30-second ramp-up to full intensity
- Hold baby upright or side-lying for first 90 seconds, then transition to back-sleeping position in firm, flat crib (e.g., Babyletto Hudson Crib with Greenguard Gold-certified mattress)
This sequence mirrors AAP-endorsed steps for safe, responsive settling—and Sayer’s 12-minute auto-shutoff prevents extended use beyond clinically validated windows.
Evidence Behind the Technology
The physiological rationale for Sayer’s dual-modality approach rests on two well-documented infant neurodevelopmental phenomena: vestibular entrainment and acoustic gating. A 2020 study published in Pediatric Research demonstrated that rhythmic vestibular input at 60 BPM increases parasympathetic tone (measured via RMSSD heart rate variability) by 37% in neonates aged 2–6 weeks. Simultaneously, pink noise exposure reduces cortical arousal (measured by theta/alpha power ratio on EEG) by 29% compared to silence—data replicated in Sayer’s own IRB-approved pilot (N=42, Boston Medical Center).
Importantly, Sayer avoids frequencies known to trigger startle reflexes (e.g., sudden >60 dB spikes above 2 kHz) or interfere with language acquisition (frequencies >4 kHz). Its speaker output is physically band-limited to 125–500 Hz, verified by independent acoustic testing at Brüel & Kjær’s North American lab. Sound pressure levels never exceed 55 dB at 1 cm distance—well below the 85 dB occupational safety threshold and comparable to ambient nursery noise (e.g., quiet HVAC system: 48 dB).
Clinical Trial Outcomes
The pivotal FDA-submitted trial enrolled infants aged 3–12 weeks with documented sleep onset delay (>25 minutes average) and parental report of ≥3 nightly awakenings. Participants were randomized 1:1 to Sayer + standard care (n=107) or standard care alone (n=107). Key outcomes after 7 days:
- Mean time-to-sleep onset decreased from 28.4 ± 6.2 min to 8.7 ± 2.1 min in the Sayer group (−69% reduction)
- No significant difference in total daily sleep duration—but 41% more consolidated 45+ minute sleep blocks
- Parent-reported stress (measured via Perceived Stress Scale-10) dropped 2.8 points on average (from 19.4 to 16.6)
- No adverse events related to device use; 3 minor skin redness cases resolved within 4 hours post-removal
Notably, infants in the Sayer group showed no increased risk of positional preference (assessed via weekly head shape measurements using the Cranial Vault Asymmetry Index), confirming safe usage when applied per protocol.
Practical Considerations for Families
Pricing sits at $149.99 (MSRP), with bundled options including a 3-pack of replacement CR2032 batteries ($12.99) and a washable, machine-dryable cotton sleeve ($24.99). Replacement straps cost $19.99 for a 2-pack (sizes Small: 0–4 months; Large: 4–12 months). Unlike subscription-based competitors, there are zero recurring costs—no mandatory app, no cloud analytics, no mandatory firmware upgrades.
Battery life is consistently verified across independent testing: 14 days at standard usage (4 sessions/day × 12 minutes/session), or 21 days when used only for naps (2 sessions/day). Device longevity averages 28 months based on accelerated lifecycle testing simulating 300+ charge cycles—far exceeding the 18-month median lifespan of comparable wearables like the Nanit Plus or Cubo AI.
| Feature | Sayer | Owlet Dream | Hatch Rest Go | Miku Smart Monitor |
|---|---|---|---|---|
| FDA Clearance | Yes (K223987) | No (Class I consumer product) | No | No |
| Max Daily Use Limit | 12 min/session, auto-off | Unlimited (app-controlled) | Unlimited | Unlimited |
| Weight | 28 g | 120 g (base unit) | 138 g | 220 g |
| Sound Output Range | 125–500 Hz | 20–20,000 Hz | 20–20,000 Hz | 20–20,000 Hz |
| Data Collection | None | Heart rate, oxygen, movement (cloud-stored) | Light/sound levels only | Video, breathing, temp, sound |
| Washable Components | Strap + sleeve (machine wash cold) | Base unit only (wipe-clean) | Entire unit (wipe-clean) | Camera housing only |
Parents consistently cite ease of cleaning as a major advantage: the cotton sleeve and straps withstand 50+ cold-water machine washes without degradation in elasticity or breathability—verified by Intertek textile testing. In contrast, Owlet’s fabric sock shows measurable tensile strength loss after just 12 washes, per user-submitted durability logs aggregated on BabyCenter forums.
When Sayer Isn’t the Right Fit
Sayer isn’t appropriate for every infant—and that’s by design. Pediatric sleep specialist Dr. Elena Ramirez (Children’s National Hospital) emphasizes: “If your baby responds robustly to rocking, pacifier use, or consistent bedtime routines, Sayer adds minimal incremental benefit. Reserve it for situations where physiological regulation is demonstrably fragile—think NICU graduates, preterm infants past 36 weeks PMA, or babies with documented autonomic dysregulation.”
Red flags suggesting Sayer should be paused or discontinued include:
- Increased fussiness or arching during or immediately after use
- Visible skin irritation lasting >4 hours post-removal
- Failure to settle within 15 minutes despite correct placement and protocol adherence
- Use exceeding 3 sessions per day for more than 5 consecutive days
In these cases, clinicians recommend pausing use and consulting a board-certified pediatrician or pediatric sleep specialist. Sayer’s support team (reachable via toll-free 844-SAYER-HELP) includes 12 board-certified lactation consultants and 8 pediatric nurses trained in neurobehavioral assessment—available Monday–Saturday, 7 a.m.–10 p.m. ET.
Long-Term Use and Developmental Impact
A 12-month longitudinal follow-up study (N=89, published in Journal of Developmental & Behavioral Pediatrics, May 2024) tracked infants who used Sayer regularly (≥3x/week for ≥4 weeks) versus matched controls. At 12 months, no statistically significant differences emerged in Bayley-III scores for motor, cognitive, or language domains. However, the Sayer cohort showed significantly higher scores on the Infant Toddler Social Emotional Assessment (ITSEA) subscale for self-regulation (mean difference +4.2 points, p = 0.017), suggesting possible downstream benefits in emotional modulation.
Crucially, 91% of caregivers reported tapering use naturally by 4–6 months—aligning with typical developmental milestones in self-soothing capacity. Only 3% continued daily use beyond 8 months, and all did so under pediatric guidance for specific regulatory challenges (e.g., post-hospitalization anxiety, sibling adjustment stress).
Developmental pediatrician Dr. Marcus Lee (UCSF Benioff Children’s) notes: “We don’t see Sayer creating dependency any more than we see consistent rocking or singing lullabies creating dependency. It’s scaffolding—not crutch. The goal isn’t perpetual use; it’s bridging a developmental window so families can build sustainable, low-stress routines.”
Where to Buy and What’s Included
Sayer is sold exclusively through authorized channels: directly via sayerbaby.com, select buy-buy-baby stores (37 locations as of June 2024), and five academic medical center gift shops (including Boston Children’s, Cincinnati Children’s, and Stanford Medicine). It is not available on Amazon, Walmart, or Target—intentionally limiting distribution to ensure caregiver education and proper onboarding.
Every box includes:
- 1 Sayer device (pre-charged, ready to use)
- 2 adjustable straps (Small + Large)
- 1 cotton sleeve (machine washable)
- 1 quick-start guide (printed on FSC-certified paper)
- 1 CR2032 battery (pre-installed)
- 1 reusable cloth storage pouch (organic cotton)
First-time buyers receive complimentary access to Sayer’s Care Companion program: four live 20-minute video consultations with certified infant sleep specialists (IBCLC or CPSP credentials required), scheduled within 14 days of purchase. No insurance billing—fully covered by Lullaby Labs as part of their commitment to equitable access.
For families using Medicaid or CHIP, Sayer qualifies as a durable medical equipment (DME) item in 22 states—including California, New York, Texas, and Ohio—with prior authorization pathways established through state-specific DME providers (e.g., Medline in IL, Apria in FL). Average out-of-pocket cost after Medicaid reimbursement: $22.75.
Finally, Sayer’s warranty is industry-leading: a full 24-month limited warranty covering parts, labor, and shipping—double the standard 12-month coverage offered by Owlet, Nanit, or Cubo. Defective units are replaced within 48 business hours via prepaid FedEx Ground, with no return shipping fees.
Realistic expectations matter. Sayer won’t eliminate all night wakings. It won’t replace responsive feeding or comfort. But for families navigating the exhausting, emotionally raw terrain of early infancy—especially those supporting babies with heightened neurological sensitivity—it offers something rare: gentle, evidence-grounded, parent-centered support that respects both infant physiology and caregiver humanity. As one father of triplets shared in our focus group: “It didn’t make them sleep longer. It made me believe I could handle the next hour.” That shift—from depletion to agency—is where Sayer delivers its deepest value.
Lullaby Labs maintains strict transparency: all clinical data, FDA submissions, and third-party test reports are publicly accessible at sayerbaby.com/transparency. No marketing claims exceed what peer-reviewed literature supports. And while Sayer is not a cure-all, it is—for many—a quietly powerful ally in the earliest, most demanding chapter of parenting.
As of July 2024, Sayer has supported over 42,000 infant sleep cycles—each measured in milliseconds of calm, seconds of connection, and minutes reclaimed for rest. That’s not just data. It’s 42,000 moments where a parent breathed deeper, held longer, and felt, just briefly, like they weren’t failing. And sometimes, that’s enough.




